Search details
1.
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
N Engl J Med
; 385(15): 1382-1392, 2021 10 07.
Article
in English
| MEDLINE | ID: mdl-34260849
2.
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Clin Infect Dis
; 75(1): e440-e449, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34718468
3.
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab.
J Transl Med
; 20(1): 134, 2022 03 18.
Article
in English
| MEDLINE | ID: mdl-35303909
4.
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 325(7): 632-644, 2021 02 16.
Article
in English
| MEDLINE | ID: mdl-33475701
5.
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.
Invest New Drugs
; 35(4): 442-450, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28161886
6.
Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies.
Cancer Cell Int
; 17: 56, 2017.
Article
in English
| MEDLINE | ID: mdl-28533703
7.
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET).
Histopathology
; 65(6): 879-96, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25039923
8.
Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests: A Blood Profiling Atlas in Cancer (BLOODPAC) Community Study.
J Mol Diagn
; 25(3): 143-155, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36828596
9.
Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization.
Arch Pathol Lab Med
; 146(3): 351-359, 2022 03 01.
Article
in English
| MEDLINE | ID: mdl-34232984
10.
Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer.
Sci Rep
; 10(1): 9805, 2020 06 17.
Article
in English
| MEDLINE | ID: mdl-32555523
11.
Cross-Platform Comparison of Computer-assisted Image Analysis Quantification of In Situ mRNA Hybridization in Investigative Pathology.
Appl Immunohistochem Mol Morphol
; 27(1): 15-26, 2019 01.
Article
in English
| MEDLINE | ID: mdl-28682833
12.
Coordinate regulation of a family of promastigote-enriched mRNAs by the 3'UTR PRE element in Leishmania mexicana.
Mol Biochem Parasitol
; 157(1): 54-64, 2008 Jan.
Article
in English
| MEDLINE | ID: mdl-18023890
13.
Global gene expression in Leishmania.
Int J Parasitol
; 37(10): 1077-86, 2007 Aug.
Article
in English
| MEDLINE | ID: mdl-17574557
14.
Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in Leishmania mexicana.
Mol Biochem Parasitol
; 146(2): 198-218, 2006 Apr.
Article
in English
| MEDLINE | ID: mdl-16430978
15.
Variability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays.
J Histochem Cytochem
; 64(12): 785-810, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27837159
16.
Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma.
Anticancer Res
; 36(7): 3277-88, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27354584
17.
Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
Anticancer Res
; 36(6): 2683-96, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-27272777
18.
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung.
PLoS One
; 8(11): e80292, 2013.
Article
in English
| MEDLINE | ID: mdl-24244672
19.
Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks.
Anticancer Res
; 31(6): 2073-81, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21737625
20.
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer.
Clin Cancer Res
; 17(20): 6582-91, 2011 Oct 15.
Article
in English
| MEDLINE | ID: mdl-21831956